BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34956094)

  • 1. Value of Contrast-Enhanced Ultrasound in Partially Cystic Papillary Thyroid Carcinomas.
    Fang F; Gong Y; Liao L; Ye F; Zuo Z; Qi Z; Li X; Niu C
    Front Endocrinol (Lausanne); 2021; 12():783670. PubMed ID: 34956094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of Contrast-Enhanced Ultrasound for Evaluation of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Fang F; Gong Y; Liao L; Ye F; Zuo Z; Li X; Zhang Q; Tang K; Xu Y; Zhang R; Chen S; Niu C
    Front Endocrinol (Lausanne); 2022; 13():812475. PubMed ID: 35185795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonographic Characteristics of Papillary Thyroid Carcinoma with Coexistent Hashimoto's Thyroiditis: Conventional Ultrasound, Acoustic Radiation Force Impulse Imaging and Contrast-Enhanced Ultrasound.
    Peng Q; Niu C; Zhang M; Peng Q; Chen S
    Ultrasound Med Biol; 2019 Feb; 45(2):471-480. PubMed ID: 30528690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Contrast-Enhanced Ultrasound in Differentiating Clinically Atypical Subacute Thyroiditis from Papillary Thyroid Carcinomas.
    Zhang Q; Liao L; Peng Q; Tang K; Xu Y; Zhang R; Liu M; Niu C
    Ultrasound Med Biol; 2021 Dec; 47(12):3384-3392. PubMed ID: 34602283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrasonographic assessment and differentiation of spontaneous degenerating cystic thyroid nodules and papillary thyroid carcinomas].
    Huang XZ; Min X; Zhou AY; Zhu W; Yuan XC; Qi Q; Xiao F; Xu P
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jan; 56(1):75-78. PubMed ID: 33472306
    [No Abstract]   [Full Text] [Related]  

  • 6. Mummified Thyroid Nodules: Conventional and Contrast-Enhanced Ultrasound Features.
    Peng Q; Niu C; Zhang Q; Zhang M; Chen S; Peng Q
    J Ultrasound Med; 2019 Feb; 38(2):441-452. PubMed ID: 30099759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic Value of Contrast-enhanced Ultrasound in Extrathyroidal Extension of Papillary Thyroid Carcinoma].
    Cai Q; Luo Y; Li X; Lan Y; Zhang Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Oct; 42(5):619-625. PubMed ID: 33131516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Contrast-Enhanced Ultrasonography in Papillary Thyroid Microcarcinoma Stratified by Size.
    Huang K; Bai Z; Bian D; Yang P; Li X; Liu Y
    Ultrasound Med Biol; 2020 Feb; 46(2):269-274. PubMed ID: 31703968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of time-intensity curve analysis of contrast-enhanced ultrasound in the differential diagnosis of thyroid nodules.
    Gu F; Han L; Yang X; Liu H; Li X; Guo K; Zhao Z; Zhou X; Luo W
    Eur J Radiol; 2018 Aug; 105():182-187. PubMed ID: 30017277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound characteristics of preoperative central cervical lymph node metastasis in papillary thyroid carcinoma.
    Ye F; Gong Y; Tang K; Xu Y; Zhang R; Chen S; Li X; Zhang Q; Liao L; Zuo Z; Niu C
    Front Endocrinol (Lausanne); 2022; 13():941905. PubMed ID: 36133315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.
    Huang Y; Wang Y; Liu L; Zhu L; Qiu Y; Zuo D; Lu X; Dong Y; Jung EM; Wang W
    Clin Hemorheol Microcirc; 2023; 83(4):409-420. PubMed ID: 36683500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partially cystic thyroid nodules: ultrasound findings of malignancy.
    Park JM; Choi Y; Kwag HJ
    Korean J Radiol; 2012; 13(5):530-5. PubMed ID: 22977318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between maximum intensity and microvessel density for differentiation of malignant from benign thyroid nodules on contrast-enhanced sonography.
    Jiang J; Shang X; Zhang H; Ma W; Xu Y; Zhou Q; Gao Y; Yu S; Qi Y
    J Ultrasound Med; 2014 Jul; 33(7):1257-63. PubMed ID: 24958412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast agent retention features in contrast-enhanced ultrasound: diagnostic performance for the prediction of papillary thyroid carcinoma.
    Jin Z; Zhu Y; Xie F; Zhang Y; Li N; Luo Y; Cao J
    Clin Imaging; 2021 Dec; 80():131-138. PubMed ID: 34315016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis.
    Chen S; Niu C; Peng Q; Tang K
    Front Endocrinol (Lausanne); 2021; 12():556851. PubMed ID: 33796065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign cystic nodules may have ultrasonographic features mimicking papillary thyroid carcinoma during interval changes.
    Kim SS; Kim MR; Mok JY; Huh JE; Jeon YK; Kim BH; Kim SJ; Kim YK; Kim IJ
    Endocr J; 2011; 58(8):633-8. PubMed ID: 21617328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer.
    Zhang Y; Zhang X; Li J; Cai Q; Qiao Z; Luo YK
    Eur Radiol; 2021 Jul; 31(7):4568-4575. PubMed ID: 33411051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Contrast-Enhanced Ultrasound in Mummified Thyroid Nodules.
    Chen S; Tang K; Gong Y; Ye F; Liao L; Li X; Zhang Q; Xu Y; Zhang R; Niu C
    Front Endocrinol (Lausanne); 2022; 13():850698. PubMed ID: 35370962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.
    Nemec U; Nemec SF; Novotny C; Weber M; Czerny C; Krestan CR
    Eur Radiol; 2012 Jun; 22(6):1357-65. PubMed ID: 22322310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of quantitative contrast-enhanced ultrasound for the prediction of lymph node metastasis in patients with papillary thyroid carcinoma.
    Luo ZY; Hong YR; Yan CX; Wang Y; Ye Q; Huang P
    Clin Hemorheol Microcirc; 2022; 80(1):37-48. PubMed ID: 33252064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.